Skip to main content
Susan Greenspan, MD, Endocrinology, Pittsburgh, PA, UPMC Presbyterian Shadyside

SusanLGreenspanMD

Endocrinology Pittsburgh, PA

Diabetes, Lipid Metabolism

Professor of Medicine, University Pittsburgh

Dr. Greenspan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Greenspan's full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1985
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1982
  • Harvard Medical School
    Harvard Medical SchoolClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - Present
  • PA State Medical License
    PA State Medical License 1999 - 2024
  • MA State Medical License
    MA State Medical License 1981 - 2001
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2005-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
  • Pittsburgh Magazine Castle Connolly, 2005-2007, 2010-2011

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • COVID Interrupts Bone Therapy for Many; Vegan vs Mediterranean Diet
    COVID Interrupts Bone Therapy for Many; Vegan vs Mediterranean DietFebruary 14th, 2021
  • How Has COVID-19 Affected the Treatment of Osteoporosis? An IOF-NOF-ESCEO Global Survey
    How Has COVID-19 Affected the Treatment of Osteoporosis? An IOF-NOF-ESCEO Global SurveyFebruary 8th, 2021
  • Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women: A Randomized Clinical Trial
    Efficacy and Safety of Single-Dose Zoledronic Acid for Osteoporosis in Frail Elderly Women: A Randomized Clinical TrialJuly 22nd, 2020
  • Join now to see all

Grant Support

  • Osteoporosis In Older Men And WomenNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2012
  • Research Career Development CoreNational Institute On Aging2009–2011
  • Maintenance Of Skeletal Integrity In Frail EldersNational Institute On Aging2007–2011
  • Research And Development CoreNational Institute On Aging2004–2008
  • Prevention Osteoporosis Premenopausal/Postmenopausal Women W/Breast CancerNational Center For Research Resources2005
  • Once Wkly Bisphosphonate Preventing Osteoporosis In Hypogondal MenNational Center For Research Resources2005
  • F/U PTH Alendronate Combo Trmnt Osteoporosis PATH IINational Center For Research Resources2005
  • Bone Loss In Men W/Prostate Cancer Treated W/Androgen Deprivation TherapyNational Center For Research Resources2005
  • Prevention Of Osteoporosis In Men With Prostate CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
  • PTH And Alendronate In The Treatment Of OsteoporosisNational Center For Research Resources2004
  • Prevention Osteoporosis In Premenopause/PostmenopauseNational Center For Research Resources2004
  • Lasofoxifene For Women At Risk For OsteoporosisNational Center For Research Resources2004
  • Bone Loss In Men With Prostate CancerNational Center For Research Resources2004
  • Bisphosphonate Prevention Of Osteoporosis In MenNational Center For Research Resources2004
  • Bariatric Surgery Effect On Bone Mass/ Bone MetabolismNational Center For Research Resources2004
  • Reference Range For The QUS 2 Ultrasonometer For Evaluation Of OsteoporosisNational Center For Research Resources2000–2002
  • Precision Assessment Of QUS 2 UltrasonometerNational Center For Research Resources2000–2002
  • Phase III Cyclic Tiludronate--Postmenopausal OsteoporosiNational Center For Research Resources2000–2002
  • Efficacy Of QUS 2 Ultrasonometer For Diagnosis Of OsteoporosisNational Center For Research Resources2000–2002
  • Calcaneal Bone Assessment Technologies To Dual X Ray AbsorptiometryNational Center For Research Resources2000–2002
  • Screening High Risk Population For Clinically Significant Gaucher DISNational Center For Research Resources1999–2002
  • Alendronate Once Weekly For Osteoporosis PreventionNational Center For Research Resources1999–2002
  • Alendronate Once &Twice Weekly For Osteoporosis TreatmentNational Center For Research Resources1999–2002
  • Bisphosphonate-Hormonal Therapy For OsteoporosisNational Center For Research Resources1997–2002
  • Raloxifene Hydrochloride, Placebo And Premarin In Prevention Of OsteoporosisNational Center For Research Resources1995–2002
  • Efficacy Of Mk-0677 And Alendronate On Bone Turnover And DensityNational Center For Research Resources1997–2000
  • Bone Loss Prevention After Acute HIP Fracture In The ElderlyNational Center For Research Resources1997–2000
  • Alendronate On Bone Density Maintenance In Female Nursing Home PatientsNational Center For Research Resources1997–2000
  • Effect Of Alendronate, Estrogen And Combination Therapy For OsteoporosisNational Center For Research Resources1995–2000
  • Femoral Osteoporosis In Elderly WomenNational Institute On Aging1995–1999
  • Phase III Study Of Intermittent Cyclical TiludronateNational Center For Research Resources1995–1999
  • Insulinlike Growth Factor I And Bone Marker Status After HIP FractureNational Center For Research Resources1997
  • Diabetes In A Patient With OsteoporosisNational Center For Research Resources1997
  • Role Of Bisphosphonate Therapy In Maintenance Of Skeletal IntegrityNational Center For Research Resources1995–1997
  • Efficacy Of Alendronate On Bone Density Maintenance In Female Nursing Home PTSNational Center For Research Resources1996
  • Comparison Of Calcaneal Bone Assessment Technologies To Dual X Ray AbsorptiometryNational Center For Research Resources1996
  • Biochemical Correlates Of Bone LossNational Center For Research Resources1995–1996
  • HIP Fracture Risk Prediction By Quantitative Digital RadiographyNational Center For Research Resources1995
  • Finasteride Indices On Bone Mineral Metabolism In Benign Prostate HyperplasiaNational Center For Research Resources1995
  • Effect Of Pamidronate On Chronic Thyroid Hormone-Induced Bone TurnoverNational Center For Research Resources1995
  • Diurnal Variation In PTH And Calcium While On Alendronate TherapyNational Center For Research Resources1995

Professional Memberships

Hospital Affiliations